Comparative Immunogenicity Assessment of Biosimilars

Future Oncology - United Kingdom
doi 10.2217/fon-2018-0553
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Biosimilars: Key Regulatory Considerations and Similarity Assessment Tools

Biotechnology and Bioengineering
Applied MicrobiologyBiotechnologyBioengineering
2017English

Biosimilars

ESMO Open
Cancer ResearchOncology
2018English

Biosimilars 2.0

mAbs
AllergyImmunology
2011English

Immunogenicity for Antisense Oligonucleotides: A Risk-Based Assessment

Bioanalysis
PharmacologyAnalytical ChemistryMedical Laboratory TechnologyClinical BiochemistryMedicineToxicologyPharmaceutics
2019English

Comparative Immunogenicity and Structural Analysis of Epitopes of Different Bacterial L-Asparaginases

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Biosimilars in Medicine

Era's journal of medical research
2017English

Biosimilars: Approval and Acceptance?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

TCPRO: An In-Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity

Biophysical Journal
Biophysics
2019English

Comparative Immunogenicity Evaluation of Characterized Chitosan-Based and Other Adjuvants for Inactivated Influenza Vaccines

Epidemiology and Vaccine Prevention
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy